All Stories

  1. The Role of Polyunsaturated Fatty Acids (PUFAs) in the Primary Prevention of Allergic Diseases in Children: A Position Paper of the SIAIP Primary and Secondary Prevention of Allergic Diseases and Nutraceuticals Committees
  2. Clinical and Mechanistic Evidence for Comano Thermal Water: A Narrative Review
  3. Multidisciplinary Delphi Consensus on the Clinical Use of Intranasal Carboxymethyl-β-Glucan-Resveratrol: Evidence-Based Recommendations for Upper Airway Diseases
  4. Intranasal Resveratrol Plus Carboxymethyl-β-Glucan: A Promising Option in Clinical Practice
  5. The Role of Zinc in Pediatric Respiratory Infections: Evidence from Clinical Trials and Real-World Studies
  6. The Role of Zinc in Pediatric Asthma and Allergic Rhinitis: Mechanisms and Clinical Implications
  7. Vitamin C in Allergy Mechanisms and for Managing Allergic Diseases: A Narrative Review
  8. Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on a Narrative Review
  9. RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists
  10. An Updated Reappraisal of Dupilumab in Children and Adolescents with Severe Asthma
  11. Exploring the Role of Lactoferrin in Managing Allergic Airway Diseases among Children: Unrevealing a Potential Breakthrough
  12. COVID-19 Pediatric Follow-Up: Respiratory Long COVID-Associated Comorbidities and Lung Ultrasound Alterations in a Cohort of Italian Children
  13. A combined treatment for patients with dry eye and associated laryngopharyngeal reflux: a real-life approach
  14. Assessment of Symptom Perception by Visual Analog Scale in Children with Newly-Diagnosed Allergic Rhinitis: The Link with Asthma
  15. Oral Mannitol for Bowel Preparation: A Safe and Effective Reappraisal
  16. Reliability of Total Serum IgE Levels to Define Type 2 High and Low Asthma Phenotypes
  17. Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections
  18. Sobrerol: New Perspectives to Manage Patients with Frequent Respiratory Infections
  19. COVID-19 vaccines and retinal microvasculature: Comment
  20. Androgen receptor (CAG)n repeat polymorphism and risk of sudden cardiac death originated from coronary artery disease: Correspondence
  21. Antibody responses to second doses of COVID-19 vaccination in lung cancer patients: comment
  22. Vacuolar ATPase subunit H regulates growth development and pathogenicity of Penicillium digitatum
  23. Response to the COVID‐19 pandemic of dental hygienist: Correspondence
  24. Antifungal activity of 40 plant essential oil components against Diaporthe fusicola from postharvest kiwifruits and their possible action mode
  25. Re: “Association of the Interleukin 1B-31*C Proinflammatory Allele with the Severity of COVID-19 Patients: A Preliminary Report” by Galán-Huerta et al.
  26. Covid‐19 vaccination landscape in Malta through social media: Correspondence
  27. Haematological changes in COVID-19: correspondence
  28. Monkeypox virus among seafarers
  29. Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
  30. Differential Expression Patterns of Indoleamine 2,3-Dioxygenase 1 and Other Tryptophan and Arginine Catabolic Pathway Genes in Dengue Correlate with Clinical Severity-Pilot Study Results
  31. Long-COVID-19 patients and sleep disorders: correspondence
  32. COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
  33. Probiotics in asthma management: fiction or truth?
  34. Efficacy and Safety of Oral Probiotics in Children with Allergic Rhinitis: A Review
  35. Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
  36. Dog, cat, pet to human and human to pet COVID‐19 transmission
  37. Sonography of monkeypox: comment
  38. COVID-19 vaccine-related psychiatric adverse events: Correspondence
  39. Comment on “Arthritis due to monkeypox virus: A case report” by Lombès A et al. Joint Bone Spine. 2023;90:105492
  40. Correspondence on Monkeypox
  41. Fake News and vaccine: Correspondence
  42. IL-10-1082G/a gene polymorphism and the risk of acute lung injury/respiratory distress syndrome: Correspondence
  43. Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
  44. Letter to the Editor: Voice Therapy in the Context of the COVID-19 Pandemic: Guidelines for Clinical Practice
  45. Monkeypox, pregnancy, and evidence of vertical transmission: reply
  46. Phototherapies for the management of cutaneous lesion from monleypox: Correspondence
  47. Social communication pathways to COVID-19 vaccine side-effect correspondence
  48. Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis
  49. Successful application of photodynamic therapy for skin infection caused by Corynespora cassiicola in an immunosuppressed patient and literature review
  50. Surgery plus photodynamic therapy for a diabetic patient with cutaneous infectious granuloma caused by Curvularia lunata
  51. Effect of SARS-CoV-2 infection on trauma throughput to alternative elective care approaches
  52. Artificial Intelligence, Chatbots, Plagiarism and Basic Honesty: Comment
  53. Heterologous mRNA-based COVID-19 booster strategies: Comment
  54. Interleukin 17A and 17F polymorphisms and asthma susceptibility: Correspondence
  55. Lichen planus, COVID-19 infection and vaccination: correspondence
  56. “PALLCARE Seva”—A Beacon Amid the Catastrophic COVID-19 Times: Correspondence
  57. Willingness of college students to receive COVID-19 heterologous vaccination: Comment
  58. Environmental perspectives of monkeypox virus: correspondence
  59. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination: Comment
  60. An autopsy case report of aortic dissection after mRNA COVID-19 vaccination: correspondence
  61. Comment on published article on “The first imported case of monkeypox in Taiwan”
  62. Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV
  63. Monkeypox and pregnancy: correspondence
  64. Re: “Acupuncture in Multidisciplinary Treatment for Post-COVID-19 Syndrome” by Trager et al.
  65. Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence
  66. Commentary on “Delayed prosthetic seroma: a localized inflammatory response to COVID vaccination and infection? by Chan SL, Hsieh MKH, Mok JWL & Kong TY”
  67. STOX1 promotor region −922 T > C polymorphism and early-onset preeclampsia: correspondence
  68. Cardiac magnetic resonance imaging findings in COVID-19 vaccine-related myocarditis
  69. Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
  70. Waning of humoral immunity and COVID-19 vaccine: comment
  71. Confirmation bias and vaccine-related beliefs and COVID-19: correspondence
  72. COVID-19 financing strategies for refugees and migrants in the Eastern Mediterranean Region
  73. Comment on “COVID-19 vaccine efficacy”
  74. Vitamin D receptor polymorphisms and cardiometabolic conditions: Correspondence
  75. CoronaVac, BNT162b2 and heterologous COVID-19 vaccine and ventricular assist device: Correspondence
  76. Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence
  77. Comment on “Determinants of vaccination behavior among university students”
  78. COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence
  79. COVID-19 vaccine and its effect on sperm
  80. Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
  81. Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
  82. Comments on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
  83. Comments on intron 4 VNTR polymorphism in theNOS3gene and bipolar disorder
  84. Immune thrombocytopenic purpura and COVID-19 vaccination
  85. Immunonochromatography Test and Overestimation in Molecular Epidemiology for Rotavirus
  86. Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
  87. Letter to the Editor: Unintended Consequences of Hybrid Work from Home Clinical Academic Environment
  88. Molecular Epidemiology Investigation for Adenovirus in Stool Sample Adjusted Incidence
  89. Monkeypox and emergency medicine clinicians
  90. SARS-CoV-2 in cats from military bases: correspondence
  91. Willingness to pay for a COVID-19 vaccine for oneself and one's child: Correspondence
  92. Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19
  93. Letters to the Editor
  94. SARS-CoV-2 reinfection rate in vaccinated Hospital workers: correspondence
  95. Letter to the editor: COVID ‐19 vaccinations in pregnancy
  96. About anti-SARS-CoV-2 IgG antibodies pre- and post-vaccination behavior in health workers
  97. Effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: Correspondence human vaccines & immunotherapeutics
  98. Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis and nivolumab
  99. Mass Shooting Incidents, Prehospital Management, and Safety During Crisis
  100. Letter to the Editor: COVID‑19 Vaccine Uptake Among Adolescents and Young Adults Diagnosed with Cancer: Correspondence
  101. Management of patients undergoing cataract surgery: An Italian survey
  102. Vaccine hesitancy in the refugee, immigrant, and migrant population: Correspondence
  103. Clinical Characterization of Inpatients with Acute Conjunctivitis: A Retrospective Analysis by Natural Language Processing and Machine Learning
  104. Stigma and Monkeypox: Correspondence
  105. Probiotics in managing pediatricasthma: Is this a viable road?
  106. Comment on “Aspects scanographiques de la pneumopathie à COVID-19”
  107. Correlation Between Drug Resistance and Virulence of Candida Isolates from Patients with Candidiasis
  108. Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
  109. Genetically predicted vitamin K levels and risk of osteoarthritis: Correspondence
  110. Monkeypox Outbreak and Implications for Dental Practice
  111. Polydatin and COVID-19
  112. SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
  113. Split-dosing of coronavirus disease 2019 vaccines
  114. Oral Immunotherapy for Children with Cow’s Milk Allergy: A Practical Approach
  115. Autopsy Histopathologic Cardiac Findings Following the Second COVID-19 Vaccine Dose
  116. Safety and adverse events following COVID‐19 vaccination and epilepsy: Correspondence
  117. COVID ‐19 vaccination and rheumatoid arthritis in older patients: Correspondence
  118. Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: Correspondence
  119. Safety of mRNA BNT162b2 COVID-19 (Pfizer-BioNtech) vaccine in children aged 5-11 years: Correspondence
  120. Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al
  121. Knowledge and attitudes of pregnant women on maternal immunization against COVID-19: correspondence
  122. Monkeypox Virus Detection and Deep Learning-based Approaches: Correspondence
  123. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China
  124. Patients with type 2 diabetes mellitus and response to COVID-19 BNT162b2 mRNA vaccine: correspondence
  125. Post-SARS-CoV-2 vaccination COVID toes and fingers correspondence
  126. VDR gene polymorphisms and susceptibility to COVID‐19: Correspondence
  127. Seroconversion after inactive SARS-CoV-2 vaccination and obesity: Correspondence
  128. A Brief Review of Local Bacteriotherapy for Preventing Respiratory Infections
  129. Comment on ‘Optimisation of individual cardiovascular risk assessment using a commercial test for genetic polymorphisms’
  130. SDC4-rs1981429, ATM-rs228590 and biomarkers of breast cancer risk
  131. Comment on “intralesional injection of MMR , BCG , and candida albicans antigen in treatment of multiple recalcitrant warts”
  132. Omalizumab and allergen immunotherapy for respiratory allergies
  133. Nasal microbiome in chronic rhinosinusitis
  134. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients
  135. COVID-19, vaccination and neuropsychiatric sequelae: Correspondence
  136. D‐dimer, pulmonary embolus, spontaneous intracranial haemorrhage, COVID ‐19 and lung transplant recipient
  137. Motivational interviewing approach and COVID-19 vaccine hesitancy: Correspondence
  138. Mouth sores and monkeypox: A consideration
  139. Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
  140. The first few cases of monkeypox infection in non-endemic countries: Correspondence
  141. Unvaccinated caregivers who plan to vaccinate their children: Correspondence
  142. COVID-19 Vaccine Side Effects among Early-Vaccinated Healthcare Workers: Correspondence
  143. Giant cell vasculitis post-COVID-19 mRNA vaccine and COVID-19 asymptomatic infection: Correspondence
  144. Oral mannitol for bowel preparation: a dose-finding phase II study
  145. Inactivated COVID-19 vaccines, HBV and HIV: Correspondence
  146. COVID-19 Vaccines for Children with Developmental Disabilities: Correspondence
  147. Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19: correspondence
  148. Inflammatory bowel disease and attitudes towards COVID‐19 vaccination
  149. Cutaneous adverse events following the inactivated and mRNA COVID‐19 vaccines: Correspondence
  150. The mitochondrial complex I proteins of Candida albicans moderate phagocytosis and the production of pro‐inflammatory cytokines in murine macrophages and dendritic cells
  151. China and monkeypox: Correspondence
  152. Determinants of COVID‐19 vaccine uptake among healthcare professionals and the general population: Correspondence
  153. COVID-19 and Disruptions to HIV Testing and Prevention
  154. A Commentary on “Clinical characteristics of human monkeypox laboratory confirmed cases: Lessons learned from observational studies” (Int J Surg 2022;104:106795)
  155. Correspondence on “Anti-SARS-Co-2 Monoclonal Antibodies and Severe Covid-19 in Kidney Transplant Patients”
  156. Correspondence on international collaboration for addressing mental health problem during the Ukraine war crisis
  157. Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
  158. Re: Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients by Peghin et al.
  159. SARS-CoV-2 vaccine as a potential trigger for narcolepsy
  160. Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV
  161. Seroconversion after COVID‐19 vaccination and heart transplant recipients: Correspondence
  162. [Retracted] Tumor suppressor role of miR-217 in human epithelial ovarian cancer by targeting IGF1R
  163. Addressing COVID-19 vaccine hesitancy
  164. Effects of COVID ‐19 vaccinations on platelets: Correspondence
  165. Probiotics in Allergic Rhinitis Management: Is There a Positioning for Them?
  166. Monkeypox and Clinical Concern
  167. Positron Emission Tomography–Computed Tomography in the Evaluation of Fever of Unknown Origin: Correspondence
  168. Variables Associated With COVID-19 Vaccination Among Israeli Adolescents: Correspondence
  169. COVID-19, intradiscal ozone therapy and back pain: a correspondence
  170. Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
  171. Lymphocyte Subsets in Mild COVID-19
  172. Vaccine-Induced Myocarditis: Correspondence
  173. Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment
  174. Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose
  175. S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis
  176. S5.3d How mitochondrial complex I proteins in Candida albicans moderate phagocytosis and the production of pro-inflammatory cytokines in murine macrophages and dendritic cells
  177. Public attitudes on social media toward vaccination and COVID-19 pandemic: correspondence
  178. Re: “The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case–Control Study” by Rayati Damavandi et al.
  179. Re: COVID ‐19 vaccine associated cervical lymphadenopathy: correspondence
  180. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines
  181. Ukraine crisis, war and cardiovascular challenges
  182. War in Ukraine and women's and perinatal health: Correspondence
  183. War, Participants and Victims of Armed Conflicts, and Hostilities Rehabilitation: A Comment on the Report from Ukraine
  184. (R)Evolution in Allergic Rhinitis Add-On Therapy: From Probiotics to Postbiotics and Parabiotics
  185. Circulating MicroRNA-423-5p in Hypertensive Patients with Heart Failure: Correspondence
  186. Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence
  187. Monkeypox in the Pregnant Woman and Obstetric Problem
  188. Role of FEF 25–75 in children sent by primary care paediatricians for asthma diagnosis
  189. Letter to the editor: COVID ‐19 vaccination uptake among pregnant individuals
  190. Maternal Thrombophilic and Hypofibrinolytic Genetic Variants and Idiopathic Recurrent Pregnancy Loss: Correspondence
  191. Publication Without any Plagiarism: Correspondence
  192. Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic
  193. Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
  194. Monkeypox and Identify-Isolate-Inform (3I) Tool: Correspondence
  195. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
  196. COVID-19 lockdown and demand for health care of children and adolescents with burn
  197. Re: COVID-19 Vaccine–Induced Multisystem Inflammatory Syndrome With Polyserositis Detected by FDG PET/CT
  198. Fever, COVID‐19 vaccination, and Brugada syndrome: Incidence and management—Correspondence
  199. Comment on D’Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800–1806
  200. Autoimmune hepatitis triggered by COVID-19 vaccination: correspondence
  201. Pharmacokinetics of mannitol after oral administration
  202. Neonate, infected mother and monkeypox: the present concern
  203. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS
  204. COVID-19 Vaccination and Anti-CD19 CAR T Cell-Induced B Cell Aplasia
  205. COVID-19 health information sources and vaccine hesitancy: Correspondence
  206. Commentary on “The Ukrainian refugee crisis and the COVID-19 pandemic in Europe” (Int J Surg 2022;102:106671)
  207. Correspondence on ‘COVID-19 vaccine efficacy in a rapidly changing landscape’
  208. Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
  209. Myocarditis and COVID-19 mRNA vaccination
  210. Persistent COVID-19 symptoms after diagnosis: Correspondence
  211. Reply to: "The spoils of war and the long-term spoiling of health conditions of entire nations"
  212. Third dose of m RNA COVID ‐19 vaccine and response: Correspondence
  213. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
  214. Routine OSCE to identify core communication skills required for counseling a vaccine-hesitant patient: Correspondence
  215. A comment on ‘ COVID ‐19 vaccine hesitancy and acceptance among pregnant people’
  216. Correspondence on Outcomes of COVID-19 in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients
  217. Guillain–Barré Syndrome with Normal Nerve Conduction Study Associated with COVID-19 Infection in a Child: Correspondence
  218. Attitudes and behavior of medical students toward receiving the COVID-19 vaccine
  219. Factors Associated With COVID-19 Breakthrough Infections: Correspondence
  220. Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
  221. COVID ‐19 vaccination coverage, vaccine hesitancy and opioid use disorder: Correspondence
  222. Refusal to Walk and Ptosis as an Atypical Presentation of Kawasaki Disease
  223. Myocarditis after COVID‐19 mRNA vaccination: Correspondence
  224. COVID‐19 vaccination, semen concentration, and total motile count
  225. Factors affecting the willingness to get vaccinated against COVID‐19: Correspondence
  226. Lower Extremity Compartment Syndrome, COVID-19 Myositis and Vaccination: Correspondence
  227. The Probiotics in Pediatric Asthma Management (PROPAM) study
  228. A commentary on “post-SARS-CoV-2-vaccine shoulder pain: Is it relevant to the vaccine injection? – Correspondence” (int J surg 2022;100:106603)
  229. Comment on “Maternal uniparental disomy 21 in association with low-level mosaic trisomy 21 at amniocentesis”
  230. Letters to the Editor
  231. Oxygen saturation in pregnant individuals with hemoglobinopathy and COVID-19
  232. Pituitary apoplexy and COVID-19 vaccination
  233. The plasma membrane H+-ATPase is critical for cell growth and pathogenicity in Penicillium digitatum
  234. Probiotics in Children with Asthma
  235. Letter to the Editor re: “Refractive and Vision Status in Down Syndrome: A Comparative Study”
  236. Nutrition for seafarers during and after COVID-19
  237. Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies
  238. COVID-19 and Rhino-Cerebral Mucormycosis: Correspondence
  239. Comparing available treatments for pollen-induced allergic rhinitis in children
  240. Acute kidney injury after COVID-19 vaccines: correspondence
  241. MONKEYPOX AND HEADACHE: LITTLE MENTIONED CLINICAL PRESENTATION OF THE CURRENT INFECTIOUS DISEASE PROBLEM
  242. Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
  243. COVID-19 vaccination and lung transplant recipients
  244. COVID-19–Associated Immune Thrombocytopenia in a Toddler: Correspondence
  245. Correspondence on Intention to vaccinate young children against COVID-19
  246. Factors influencing COVID-19 vaccine acceptance and hesitancy: Correspondence
  247. Predictors of COVID-19 Vaccine Uptake in Health Care Workers: Correspondence
  248. Factors associated with wheezing recurrence in clinical practice
  249. Alpha-Glycerylphosphorylcholine and D-Panthenol Eye Drops in Patients Undergoing Cataract Surgery
  250. 5-aminolevulinic acid-photodynamic therapy ameliorates cutaneous granuloma by killing drug-resistant Mycobacterium marinum
  251. 5-aminolevulinic acid-photodynamic therapy as a potential approach for kerion
  252. Death Notices
  253. Atypical manifestations of acute viral hepatitis A: Correspondence
  254. Divergent EGFR/MAPK-Mediated Immune Responses to Clinical Candida Pathogens in Vulvovaginal Candidiasis
  255. Time-related aortic inflammatory response in severely or critical COVID-19
  256. Flooding and Change of COVID-19 Incidence: an Observation
  257. Transient Fanconi Syndrome in a Child with Acute COVID-19 Infection: Correspondence
  258. COVID-19 lockdown and increased incidence of dengue: A note
  259. Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”
  260. Admission hemoglobin level and prognosis of type 2 diabetes mellitus and possible confounding factors: Correspondence
  261. COVID-19 mRNA Vaccines and False Reactivity in Rapid Plasma Reagin
  262. Primary care experience on Stimunex® gocce in children with recurrent respiratory infections: a real-world study during the COVID-19 pandemic era
  263. Case Report and Literature Review of Impetigo-Like Tinea Faciei
  264. Letter to the Editor: Variability in Management Practices and Surgical Decision Making in Spinal Tuberculosis
  265. Vaccine Hesitancy and Refusal for Childhood Vaccines and the COVID-19 Vaccine
  266. Lymphohistiocytic Myocarditis and Moderna mRNA-1273 Vaccine
  267. MicroRNA in Bile Cytologic Samples
  268. Deletion of Non-histidine Domains of Histidine Kinase CHK1 Diminishes the Infectivity of Candida albicans in an Oral Mucosal Model
  269. Re: Alterations in 18F-FDG PET/MRI and 15O-Water PET Brain Findings in Patients With Neurological Symptoms After COVID-19 Vaccination: A Pilot Study
  270. A Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance
  271. Pediatric Asthma: A Daily Challenge
  272. Comment on “Usefulness of lung ultrasound in the early identification of severe COVID-19: results from a prospective study”
  273. Post SARS-CoV-2 Vaccine Chilblains-like Lesions
  274. Ulcerative Colitis Relapse After COVID-19 Vaccination: Correspondence
  275. Cartridge-Based Nucleic Acid Amplification Test for the Diagnosis of Pulmonary Tuberculosis: correspondence
  276. A post hoc analysis on the effects of a probiotic mixture on asthma exacerbation frequency in schoolchildren
  277. Multiple sites of thrombosis without thrombocytopenia and COVID-19 vaccine: Correspondence
  278. Atypical Optic Neuritis After COVID-19 Vaccination
  279. The PRObiotics in Pediatric Asthma Management (PROPAM) study: A post hoc analysis in preschoolers
  280. COVID-19 Vaccine Hesitancy Among Deployed Personnel: Correspondence
  281. Postinfectious Olfactory Complaints: A Follow-up Study
  282. Follow-up of patients with suspected COVID-19
  283. Presence of Malassezia Hyphae Is Correlated with Pathogenesis of Seborrheic Dermatitis
  284. Ceroid Lipofuscinosis in Children: Correspondence
  285. Timing of Tocilizumab Use and COVID-19
  286. MNS16A VNTR polymorphic sequence variations of the TERT gene and bladder cancer: Correspondence
  287. Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice
  288. Response to Pairojkul et al. Integration of Specialist Palliative Care into Tertiary Hospitals: A Multicenter Point Prevalence Survey from Thailand (DOI: 10.1089/pmr.2021.0003)
  289. Commentary on “Late seroma of the breast in association with COVID-19 infection: two case reports” by Martínez Núñez P, Pérez González M & Juárez Cordero A
  290. The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706)
  291. Adrenal haemorrhage and COVID-19 vaccine-induced immune thrombotic thrombocytopenia: correspondence
  292. Correspondence on “Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination”
  293. Pleural Fluid Cholesterol, Transudates, and Exudates: Correspondence
  294. Correspondence on “Hyperextension following two different designs of fixed-bearing posterior-stabilized total knee arthroplasty”
  295. Letter regarding the Published Article “Evaluation of Aortic Elasticity Parameters in Survivors of COVID-19 Using Echocardiography Imaging”
  296. Association between treatment awareness and uncontrolled asthma in adolescents
  297. AIDS and monkeypox: Cooccurrence and clinical concern on immunodeficiency
  298. Abnormal subcutaneous foreign body seen in chest radiography on checkup: an observation in a tropical country
  299. Acute appendicitis, foreign bodies and COVID-19 vaccination: correspondence
  300. Antidepressant Compliance in Depression during the COVID Pandemic: Correspondence
  301. Atypical wound presentation in monkeypox
  302. Bariatric surgery on type 2 diabetes: Correspondence
  303. Biological effects associated with internal and external contamination of diagnostic nuclear medicine sources: Correspondence
  304. Body mass index, outcome, patients, and varicose vein surgery: Correspondence
  305. Branch retinal vein occlusion and COVID-19 vaccination: Correspondence
  306. CD4+ count change after COVID-19 vaccination: Observation on HIV-infected vaccine recipient
  307. COVID-19 Diagnostic Laboratory Capacity: a View from Indochina
  308. COVID-19 Vaccination in Cancer Patients: Correspondence
  309. COVID-19 coinfection with Mycobacterium abscessus: A note
  310. COVID-19 incidence and local average rainfall: An analysis from a tropical monsoon area
  311. COVID-19 vaccine and autoimmune hepatitis
  312. Chikungunya Rickettsial Coinfection
  313. Comment on “Beliefs, barriers, and acceptance associated with COVID-19 vaccination among University students”
  314. Comment on “onlay and sublay (retrorectus) mesh repair for incisional hernia”
  315. Conjunctivitis can be a possible clinical presentation of monkeypox
  316. Correspondence on “Determinants of COVID-19 in the police”
  317. Correspondence on ‘Coronavirus disease 2019 in patients with cardiovascular disease’
  318. Correspondence - “Bone health, HIV-infected children, antiretroviral therapy, and hemoglobinopathy”
  319. Cough: A possible clinical presentation of monkeypox
  320. Cysticercus pisiformis in European wild rabbit (Oryctolagus cuniculus) Spain
  321. Diarrhea and monkeypox: a consideration
  322. Discharge against medical advice in patients during the COVID-19 outbreak: Correspondence
  323. Ergosterol depletion under bifonazole treatment induces cell membrane damage and triggers a ROS-mediated mitochondrial apoptosis in Penicillium expansum
  324. Estimated Adjusted Rate of Asymptomatic COVID-19 Among General Pediatric Population Based on Anti-Nucleocapsid Antibody Test
  325. Expected Change of Limit of Detection Threshold of Rapid Diagnostic Tool Due to Omicron SARS CoV2 Subvariants
  326. Expected rate of liver fluke-related cholangiocarcinoma in endemic area of liver fluke with antiparasitic drug distribution program for disease control in Thailand
  327. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography, hodgkin's lymphoma, COVID vaccination, and appropriate investigation time
  328. Genetic polymorphism of toll-like receptors in HIV-I infected patient and tuberculosis Co-Infection
  329. Hand-foot-and-mouth disease, tomato flu, and surgery
  330. Healthcare professionals & adverse events of ChAdOx1 nCoV-19 coronavirus vaccine
  331. Holy facemask, spiritual public health dimension, and COVID-19 prevention
  332. Immunity after mRNA COVID-19 vaccine and immunosuppressive therapy: correspondence
  333. Laboratory Adjusted Maternal PCR Cycle Threshold Cutoff Value for COVID-19
  334. Living with type 2 diabetes in COVID-19: Correspondence
  335. Low hematocrit is very common among monkeypox male cases: observations
  336. Multiple evanescent white dot syndrome (MEWDS) and inactivated COVID-19 vaccination
  337. Myocarditis following mRNA-Based COVID-19 Vaccines: Correspondence
  338. Novel coronavirus disease in kidney-transplant recipients: Correspondence
  339. Post immunization COVID-19 disease: Correspondence
  340. Pregnancy in thalassemia: Correspondence
  341. Prevalence of point-of-care ultrasound devices in Canada
  342. Problem due to SARS CoV2 Nucleocapsid Variant in Term of Cycling Time Value
  343. Re: “Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves’ Disease: A Case Report”
  344. Re: Pre-operative COVID-19 screening for urologic patients
  345. Retracted articles in Gastroenterology
  346. SARS CoV2 Variant Delta and Delta Plus, Molecular Change and Expected Impact of Response to COVID-19 Vaccine
  347. Salivary proteome profile during the fertile phase of menstrual cycle: Correspondence
  348. Serum interleukin-33 level and psoriasis diagnosis
  349. Social media behavior in plastic surgery practice: Correspondence
  350. TXNRD2 (rs35934224) CT genotype and primary open-angle glaucoma
  351. Tumor necrotic factor pathway, monkeypox, and tuberculosis: Correspondence
  352. Vascular retinal findings after coronavirus disease 2019 vaccination: a correspondence
  353. Venereal disease research laboratory serology after COVID-19 vaccination: The first report
  354. War and surgery
  355. What role should medical journals play during COVID-19?
  356. COVID-19 Vaccination, Breastfeeding, and Milk Supply
  357. Procedimientos electrofisiológicos y pandémicos de COVID-19
  358. Health Literacy among Older Adults during COVID-19 Pandemic
  359. COVID-19 vaccinations for seafarers on ocean-going vessels
  360. Flexible Bedside Bronchoscopy Using Closed Sheath System and COVID-19 Patients
  361. Association of Dry Eye with Laryngopharyngeal Reflux in Clinical Practice. Reply to Lechien et al
  362. Plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis
  363. Margem de Segurança para Hiperviscosidade Plasmática para Prevenção de Trombose em Pacientes com Doença Cardiovascular após Vacinação contra COVID-19
  364. Hematological Malignancy Patients, COVID-19, and Favipiravir
  365. Characterization of T2-Low and T2-High Asthma Phenotypes in Real-Life
  366. Allergen Immunotherapy management during vaccinations: An international survey
  367. Bronchial obstruction perception and uncontrolled asthma in clinical practice
  368. Inadequate literacy is associated with uncontrolled asthma in adolescents
  369. Active compound identification by screening 33 essential oil monomers against Botryosphaeria dothidea from postharvest kiwifruit and its potential action mode
  370. Letter to the Editor Regarding First Admission Neutrophil–Lymphocyte Ratio and Ischemic Stroke
  371. Agreements and controversies of national guidelines for bronchiolitis: Results from an Italian survey
  372. Asthma severity perception in Italian children: A nationwide cross‐sectional study
  373. Fiebre maculosa de las Montañas Rocosas, dengue y chikungunya y otras infecciones tropicales transmitidas por vectores
  374. Allergen immunotherapy in children with otitis media with effusion: a preliminary experience
  375. Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
  376. Hematological Findings and Clinical Severity in COVID-19 in Pediatric Patients
  377. COVID-19 Outbreak, Lockdown and Impact on Pediatric Nutritional Status: A Preliminary Observation
  378. Comment on: Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series
  379. The role of bronchodilation testing in children and adolescents with asthma in clinical practice
  380. Vitamin D Status and Lipid Profile
  381. Association of Dry Eye with Laryngopharyngeal Reflux in Clinical Practice
  382. The unmet needs for identifying the ideal bowel preparation
  383. Clinical characterization of T2 low phenotype
  384. Phenotyping asthmatic outpatients by cluster analysis in a real-world setting
  385. Evaluation of Droplet Digital PCR Assay for the Diagnosis of Candidemia in Blood Samples
  386. Asthma Control Test to Identify Uncontrolled Asthma in Pediatric Clinical Practice
  387. Steroid-sparing effect of mepolizumab in children with severe eosinophilic nonallergic asthma
  388. The challenge of asthma control grading in clinical practice
  389. Turbinate Hypertrophy, Allergic Rhinitis, and Otitis Media
  390. Levodropropizine in children: over thirty years of clinical experience
  391. Management of recurrent cystitis in clinical practice: a nationwide survey
  392. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD
  393. Unaffected asthma control in children with mild asthma after COVID‐19
  394. COVID-19, nasal secretion, nasal clearance, and SNOT-22 score
  395. Turbinate Hypertrophy, Allergic Rhinitis, and Otitis Media
  396. A randomized, double-blind, placebo- -controlled study to investigate the use of bacteriophages in patients with chronic rhinosinusitis with nasal polyps
  397. OM-85 in the prevention of respiratory infections: State-of-the-art and future perspectives in clinical practice
  398. Pidotimod as add-on therapy in patients with pollen-induced allergic rhinitis and asthma and associated respiratory infections
  399. The comparison between children and adolescents with asthma provided by the real-world “ControL’Asma” study
  400. Erratum
  401. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi’s Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties
  402. Impact that the COVID‐19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review
  403. A Survey on the Management of Children with Asthma in Primary Care Setting in Italy
  404. Vernal keratoconjunctivitis: An update
  405. COVID-19 Pandemic and Drug Use Disorder
  406. Natural remedies for acute post-viral cough in children
  407. Infusion of Convalescent Plasma is associated with Clinical Improvement in Critically Ill Patients With Covid-19: A Comment
  408. The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world “ControL’Asma” study
  409. Under-prescription of allergen-immunotherapy: why is it important to prescribe it in childhood instead?
  410. Smell impairment in patients with allergic rhinitis
  411. CYP2C19*2 polymorphism and clopidogrel resistance
  412. An evolutionarily diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans
  413. COVID-19: the difference between the nose and the lung
  414. Acute cough in children and adolescents: A systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology
  415. Chronic cough in childhood: A systematic review for practical guidance by the Italian Society of Pediatric Allergy and Immunology
  416. Functional recovery in subjects undergoing nasal surgery: a new therapeutic strategy
  417. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows
  418. Proteome-Wide Analysis of Lysine 2-Hydroxyisobutyrylation in Candida albicans
  419. Systematic Analysis of the Lysine Crotonylome and Multiple Posttranslational Modification Analysis (Acetylation, Succinylation, and Crotonylation) in Candida albicans
  420. Alternaria alternata spores shuttled by Peltate trichomes of olive leaf: A mysterious nasal cytology feature
  421. House dust mites–driven allergic rhinitis: could its natural history be modified?
  422. The real-world “ControL’Asma” study: a nationwide taskforce on asthma control in children and adolescents
  423. Allergy is not a risk factors for recurrent acute otitis media: a real-life clinical experience
  424. Obesity and Asthma: An Intriguing Link in Childhood and Adolescence
  425. Chloroquine, Malaria Prophylaxis, and COVID-19: An Observation From Endemic Area
  426. Blood urea, creatinine, and glucose levels in traumaticbrain injury
  427. Magnitude of Abortion After COVID-19 Vaccination: How About Rate?
  428. mRNA COVID-19 Vaccination and mortality of pediatric vaccine recipient, any association ?
  429. A model of transboundary migration effect in highly endemic foci of drug-resistant pulmonary tuberculosis
  430. Anti-Spike Antibody Test, Accuracy and Misidentification: Implication in Interpretation of COVID-19 Vaccine Efficacy
  431. Anticancer property of Zika virus proteins: Lack of evidence from predictive clinical bioinformatics study
  432. COVID-19 vaccination in a cancerous patient: A comment
  433. Capacity, Allocation, and Appointment System: a Challenge in Clinical Laboratory Management During a Pandemic Crisis
  434. Concurrent Zika virus infection and tuberculosis: An estimated incidence in endemic tropical country
  435. Diseases mimicking novel Wuhan coronavirus infection: an observation on negative isolated cases according to infectious control program
  436. How to Use Imperfect Tests for COVID-19: More Considerations in View of Laboratory Medicine
  437. Human Exposure Incidence, Rate of Diagnosed Rabid Animals in Clinical Laboratory, and Effect of COVID-19 Outbreak
  438. Incidence rate of tuberculosis among patients with alcoholism: a report from a highly endemic area at the Golden Triangle
  439. Influenza vaccination among patients with history of tuberculosis: an observation
  440. Interferon-gamma assay and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease: a summarization study
  441. Interrelationship between head lice infestation and nutritional status of Thai preschool nursery children in a remote community near Thailand-Cambodia international border: an observation
  442. No report of cholangiocarcinoma among HIV-infected case in endemic area: What is the possible explanation?
  443. Permeability of active ingredients of cannabis and possibility for further antituberculosis drug development
  444. Pharmacoprophylactic equivalence of rifapentine compared with isoniazid: an appraisal for HIV-infected population
  445. Post-COVID Glomerular Filtration Rate in the Elderly Cases: A Preliminary Report on 50 Cases
  446. Treg Cells and Epigenetic Regulation
  447. Tuberculosis in patients with underlying thalassemia: a consideration of common antioxidative pathway − an expressional analysis
  448. Dead body of the patient with COVID-19 and concern on disease spreading
  449. Expected RATE of vaccine-associated paralytic poliomyelitis: A simulation analysis regarding transition from the trivalent to bivalent oral poliovirus vaccine
  450. Stool examination for liver fluke detection and ultrasonography for detection of abnormal biliary tract in cholangiocarcinoma control program: A reappraisal from endemic area in indochina
  451. Dystrophic rhinitis: etiopathogenetic mechanisms and therapeutic strategy for functional recovery
  452. Primary care experience on Rinfodim 3® in children with recurrent respiratory infections
  453. The fungal-specific subunit i/j of F1FO-ATP synthase stimulates the pathogenicity of Candida albicans independent of oxidative phosphorylation
  454. Biologics to Treat Severe Asthma in Children and Adolescents: A Practical Update
  455. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  456. Mitochondrial Complex I Core Protein Regulates cAMP Signaling via Phosphodiesterase Pde2 and NAD Homeostasis in Candida albicans
  457. ControL'Asma Project: new insights
  458. Allergen immunotherapy in atopic dermatitis: Light and shadow in children
  459. Antihistamines in children and adolescents: A practical update
  460. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019
  461. HMGB1: A pleiotropic activity
  462. Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes
  463. Use of a plastic banded bag over the control body of the endoscope for COVID-19 prevention: a comment
  464. Local Bacteriotherapy – a promising preventive tool in recurrent respiratory infections
  465. Delayed surgery versus nonoperative treatment for hip fractures in post-COVID-19 situation
  466. Miocarditis fulminante y COVID-19
  467. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  468. Cough Remedies for Children and Adolescents: Current and Future Perspectives
  469. An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma
  470. Biologic Use in Allergic and Asthmatic Children and Adolescents During the COVID-19 Pandemic
  471. COVID-19 in Italy: The Point of View of the Italian Society of Pediatric Allergy and Immunology-COVID-19 Commission
  472. Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019
  473. Treg‐inducing capacity of genomic DNA of Bifidobacterium longum subsp. infantis
  474. In Vitro Activities of Ravuconazole and Isavuconazole against Dematiaceous Fungi
  475. Manifestaciones neurológicas y COVID-19
  476. The influence of smoking on asthma in the real-life
  477. The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps
  478. Antidepressant effects of 3‐(3,4‐methylenedioxy‐5‐trifluoromethyl phenyl)‐2E‐propenoic acid isobutyl amide involve TSPO‐mediated mitophagy signalling pathway
  479. Paediatric emergency department visits fell by more than 70% during the COVID‐19 lockdown in Northern Italy
  480. Clinical Characterization of the Frequent Exacerbator Phenotype in Asthma
  481. High levels of plasma fibrinogen could predict frequent asthma exacerbations
  482. Bioactive Lipids and Coronavirus
  483. Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19)
  484. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19
  485. Clinical Features and Chest CT Manifestations of Coronavirus Disease (COVID-19)
  486. FKBP5 polymorphism rs1360780 and weight loss after bariatric surgery
  487. Physiological and iTRAQ-based proteomic analyses reveal the mechanism of pinocembrin against Penicillium italicum through targeting mitochondria
  488. Retraction of publications
  489. Traumatization in medical staff helping with COVID-19 control
  490. Management of Traumatic Spinal Fracture in Patient with Coronavirus Disease 2019
  491. Oral quail egg homogenate in the treatment of allergic rhinitis: a first experience in clinical practice.
  492. Special Issues for Coronavirus Disease 2019 in Children and Adolescents
  493. Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice
  494. More mutation accumulation in Neisseria gonorrhoeae (NG) with susceptibility than that in NG with decreased susceptibility to ceftriaxone
  495. Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic
  496. Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View
  497. Allergy and Otitis Media in Clinical Practice
  498. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data
  499. Assembly and analysis of the whole genome of Arthroderma uncinatum strain T10, compared with Microsporum canis and Trichophyton rubrum
  500. COVID‐19 and Cutaneous manifestations
  501. COVID-19 and cardiovascular disorder
  502. COVID-19 and management of the corpse
  503. Cancer care under the outbreak of COVID-19
  504. Cancerous Patient with COVID-19: Note on Data from the first 3-Month Period of Disease
  505. Fecal‐oral transmission of COVID‐19
  506. Handling Egregious Plagiarism
  507. Medical personnel, COVID-19 and emotional impact
  508. Re: Thomas Loubersac, Molière Nguile-Makao, Frédéric Pouliot, Vincent Fradet, Paul Toren. Neutrophil-to-lymphocyte Ratio as a Predictive Marker of Response to Abiraterone Acetate: A Retrospective Analysis of the COU302 Study. Eur Urol Oncol 2020;3:298–305
  509. Roadblocks and COVID-19: Hope and Strict Control
  510. Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares
  511. The psycho-social effects of COVID-19 on Italian adolescents’ attitudes and behaviors
  512. Pain Management During the COVID-19 Pandemic
  513. Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach
  514. Acute care surgery and post‐operative COVID ‐19 care: a comment
  515. Sharing Alcoholic Drinks and a COVID-19 Outbreak
  516. Surgeon and Preparedness for COVID-19 Pandemic
  517. The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents
  518. Genetic Variant Severe Acute Respiratory Syndrome Coronavirus 2 Isolates in Thailand
  519. COVID‐19, School Closings, and Weight Gain
  520. HMGB1 in nasal inflammatory diseases: a reappraisal 30 years after its discovery
  521. 2019 novel coronavirus and awareness
  522. COVID-19 can present with a rash and be mistaken for dengue
  523. COVID-19 in forensic medicine unit personnel: Observation from Thailand
  524. Corrigendum to “COVID-19 in forensic medicine unit personnel: Observation from Thailand” [J Forensic Legal Med 72 May 2020, 101964]
  525. COVID-19 pneumonia in Taiwan
  526. Comment on “Chilblains‐like lesions in children following suspected COVID‐19 infection”
  527. Exaggerated information and COVID‐19 outbreak
  528. Hearing loss and COVID-19: A note
  529. Pulmonary Pathology of Early Phase 2019 Novel Coronavirus Pneumonia
  530. Radiology Management and COVID-19 in Resource Limited Setting
  531. "Run distancing" in the era of COVID-19 pandemic
  532. Variants in FGF18 Gene and Knee Osteoarthritis
  533. Chest computed tomography in children with COVID-19
  534. The antifungal pipeline: the need is established. Are there new compounds?
  535. Carpal Fracture and COVID-19 Infection: Observation from Thailand
  536. Letter to the editor: Vitamin D receptor gene BsmI polymorphism with type 2 diabetes mellitus
  537. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
  538. Biological treatment during COVID-19 outbreak
  539. COVID-19 among medical personnel in the operating room
  540. Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19)
  541. Feasibility of flow cytometry in the rhinologist’s clinic
  542. Acetaminophen in Plasma and Acute Liver Failure
  543. COVID-19 in medical personnel: observation from Thailand
  544. COVID‐19 in rural non‐resort town: Observation from Thailand
  545. High-throughput sequencing reveals the diversity of TCR β chain CDR3 repertoire in patients with severe acne
  546. PIEZO1 polymorphisms and bone mineral density
  547. Infection control protocol inside computed tomography suites during COVID-19 outbreak
  548. Ocular manifestation, eye protection, and COVID-19
  549. COVID-19 positive test result from a private hospital laboratory: Neglecting to report and problems with national infection control
  550. Serum Uric Acid Level, Alzheimer-type Dementia and Variation
  551. Asthma in the Real-World: The Relevance of Gender
  552. COVID-19, guests and crews of cruise: observation on Thai citizens
  553. Clinical features in pediatric COVID‐19
  554. Dermatoscopy of the hair compared to three alternatives for the diagnosis of pediatric Netherton syndrome
  555. 18F-FDG PET/CT and COVID-19
  556. Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents
  557. Frequency of arrhythmia in novel coronavirus 2019 infection
  558. A real-world assessment of asthma with chronic rhinosinusitis
  559. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough: New Insights for Clinical Practice
  560. Cutaneous Manifestations of Zika
  561. Daily Dengue Severity Score
  562. Incidencia del síndrome de Guillain-Barré durante el brote del virus Zika
  563. Re: Abnormally Low Hemoglobin A1c as Harbinger of HemoglobinopathyRe: Primary Care Practices’ Implementation of Patient-Team Partnership: Findings from EvidenceNOW Southwest
  564. Re: Association between enuresis and obesity in children with primary monosymptomatic nocturnal enuresis
  565. Tumor necrosis factor-α gene-1031T/C promoter polymorphism and endometriosis
  566. Neuroimaging findings in congenital Zika virus syndrome
  567. Cetirizine use in childhood: an update of a friendly 30-year drug
  568. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis
  569. Zika and spontaneous abortion
  570. Inflammation, infection, and allergy of upper airways: new insights from national and real-world studies
  571. CYP24A1 polymorphisms and breast cancer risk
  572. Allergen immunotherapy and asthma
  573. Severe asthma in children: Current goals and unmet needs
  574. The relevance of symptom perception in the management of severe asthma in adolescents
  575. CTLA4 polymorphisms and Graves’ disease
  576. G130V de novo mutation in case with nonsyndromic hearing loss without palmoplantar keratoderma
  577. Tumor necrosis factor alpha -863C/A polymorphism and Guillain-Barré Syndrome
  578. Dabrafenib in BRAFV600E mutant pilocytic astrocytoma
  579. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air ® App
  580. Total external ophthalmoplegia and Sjögren’s syndrome
  581. Laryngo-pharyngeal reflux in clinical practice: The relevance of age
  582. Diagnostic Method to Screen Taenia solium Taeniasis Carriers
  583. COVID-19 and Nasal Cytobrush Cytology
  584. COVID-19 Outbreak, Market, Food supply and Food Safety
  585. Alteration of Consciousness as Initial Presentation in COVID-19: Observation
  586. Ambient air particulate matter 10 pollutant and newly diagnosed pulmonary tuberculosis: is there any exact association?
  587. Bioinformatics analysis of Wuhan novel coronavirus pathogen: A clue for finding antiviral drug against Wuhan novel coronavirus
  588. Brain-derived neurotrophic factor as biomarker
  589. Bronchoalveolar specimen can help detect COVID-19 in suspicious case with negative PCR for nasopharyngeal specimen test
  590. CD4+ count after arabinoxylan supplementation: An observation
  591. COVID-19 Infection in Medical Laboratory Professional: a Note
  592. COVID-19 outbreak in international airport – Where the incidence case occurs?
  593. COVID-19, Antiphospholipid Syndrome and Thrombosis
  594. COVID-19: Ratio of occurrence in general people and medical personnel, an observation from the second country that disease emerged
  595. Clinical relevance of Zika symptoms in the context of a Zika Dengue epidemic
  596. Common place for COVID-19 local spreading: Observation from Thailand
  597. Computed Tomographic Findings in COVID-19
  598. Convalescent (Immune) Plasma Therapy ad COVID19
  599. Coronavirus-antibody immune complex: A nanostructure appraisal possible cause of nephropathology
  600. Cost–utility analysis for chest CT versus RT-PCR for COVID-19 detection
  601. Density of COVID-19 and mass population movement during long holiday: Simulation comparing between using holiday postponement and no holiday postponement
  602. Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling
  603. Epitope finding in 2019 novel coronavirus (2019-nCoV): The first world report
  604. Erysipelothrix rhusiopathiae and contact with snow crab
  605. Estimated Blood Glucose and Hemoglobin A1C in COVID-19: a Preliminary Summarization
  606. Expected rate of COVID-19 among returning myanmar workers from working in nearby country to their homeland
  607. Expected tuberculosis detection rate among the patients with chronic kidney disease: A report from endemic country of tuberculosis
  608. Exported wuhan novel coronavirus infection: An expected rate with reference to main destination of Chinese tourist, Thailand
  609. False-negative from screening for COVID-19 at international border post: estimated magnitude
  610. Gender and prevalence of dengue fever
  611. Hemoptysis in COVID-19: Observation
  612. Hemorrhagic Problem Among the Patients With COVID-19: Clinical Summary of 41 Thai Infected Patients
  613. Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property
  614. Human to human transmission of wuhan novel coronavirus infection outside China: Situation of the first case and what's the source of infection?
  615. Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak
  616. Imported wuhan coronavirus infection: Is there any correlation with number of immigrants from endemic area and period after the first outbreak?
  617. Incidence possibility of pulmonary Mycobacterium abscessus infection in an endemic area: onion diagram with overlapping analysis
  618. Influence of LCT rs3754689 polymorphism on inhibitor development in patients with severe hemophilia A
  619. Molecular epidemiology of tuberculous meningitis isolates from Thailand: a collective summary
  620. Outbreak of COVID-19 in Thailand: Time serial analysis on imported and local transmission cases
  621. Patients under investigation for COVID-19: Where is the first point that the patients are recruited?
  622. Patients with COVID-19 and disguising on travel history: A challenge in disease screening
  623. Platelet count among the patients with novel coronavirus 2019 infection: An observation on 46 cases
  624. Polymorphism within the 3′ untranslated region of denticleless E3 ubiquitin protein ligase homologue and survival in acral melanoma
  625. Positive screening for Wuhan novel coronavirus infection at international airport: What's the final diagnosis for positive cases
  626. Precautions list of risk countries with COVID-19 for primary prevention: Experience on case traveling from the country out of the list
  627. Proadrenomedullin and prognostic value for pneumonia
  628. RT-PCR Tests for COVID-19: Observation on Use and Cost
  629. Reappraisal on molecular epidemiology of extensively drug-resistant Mycobacterium tuberculosis isolates in Indochina: common and unique genotype in Thailand and Myanmar
  630. Recognition on Possibility of No-Fever and No-History of Travel to Risk Country Among Nurse in Rural Area of a Country That COVID-19 Already Existed: Observation
  631. Red cell distribution width in hypersensitivity pneumonitis
  632. Refusal rate for dialysis in a rural community in Indochina: What about the rate?
  633. Risk for renal carcinogenesis due to exposure to ochratoxin A contaminated roasted coffee: An assessment from Thailand
  634. Risk-prediction model for COVID-19 infection in dialysis patients
  635. Ritual objects as foreign body in chest radiographic finding: a radiological case report
  636. SARS-CoV-2 and Eosinophilia
  637. Sharing cigarette smoking and COVID-19 outbreak in a party group
  638. Spreading from hot foci of COVID-19 to another country: Observation from Thailand on disease importation by foreigner
  639. Spreading of COVID-19 in a common place: Medical architecture analysis
  640. Total distance and radius of wandering of patients with COVID19 before the first final diagnosis: GPS tracking analysis
  641. Tumor Necrosis Factor-308 G/A Polymorphism and Chronic Obstructive Pulmonary Disease Risk
  642. Zoonotic possibility of tuberculosis from domestic elephants: a case assessment from Thailand
  643. Can thermo-scan screening predict the presence of Wuhan coronavirus infection: Observation on detection rate and efficacy from Thailand
  644. Incidence of tuberculosis among malnourished patients: A summary on epidemiological data from a rural province in indochina
  645. Tuberculosis and liver fluke infection: An expressional analysis for common antioxidative pathway
  646. Acute ascites as a clinical manifestation of dengue: A case report
  647. Concurrent leptospirosis and tuberculosis: An expected incidence in endemic tropical country and rarity of the co-occurrence
  648. COVID-19 in post office worker: Observation and public health implication
  649. CYP1A1 M2 (A2455G) polymorphism with susceptibility to breast cancer
  650. GPS COVID-19 tracker - Applied informatics technology for prevention of disease spreading
  651. International globalization and spreading of novel coronavirus 2019 infection: How far and fast? A medical logistics assessment
  652. N-95 face mask for prevention of wuhan novel coronavirus: It is actually effective?
  653. Perioperative COVID-19 defense
  654. Preventive measurement against COVID-19 spreading: Immigration cessation, office closing, and holiday postponement—Simulation analysis
  655. Public tourist bus, tourist bus driver, and COVID-19 infection: A note
  656. Spray Coverage of Droplets: A Medical Biomechanics Analysis and Implication in COVID-19 Prevention
  657. Cross reactivity between recombinant parvalbumin of carp and cod and recombinant grass molecules.
  658. Vitamin D receptor gene polymorphism and ocular surface squamous cell neoplasms
  659. IFN‐γ + 874T/A polymorphism and osteomyelitis
  660. Does Food Allergy Require Any Change in Measles-Mumps-Rubella Vaccination?: Correspondence
  661. Focus on the cetirizine use in clinical practice: a reappraisal 30 years later
  662. ARID5B rs7089424 and rs10994982 and association with B-lineage ALL susceptibility
  663. Comment on: Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia
  664. Interferon-gamma Release Assays for Tuberculosis Screening in Pediatric Inflammatory Bowel Disease
  665. Re: “A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand” by Jupattanasin et al. (Viral Immunol 2019;32(7):302–307)
  666. Toxocara infection in Italian myelitis
  667. Comment on: Hemochromatosis (HFE) gene mutations (H63D and C282Y) and iron overload in beta-thalassemia major
  668. The practical clinical relevance of rhinitis classification in children with asthma
  669. Comment on “Chik sign and dengue”
  670. Galectin-3, Carbohydrate Antigen 125 and Transcatheter Aortic Valve Implantation
  671. Polymorphism in MTHFR (at SNPs 677 and 1298) in Paternal Sperm DNA and Risk of Retinoblastoma in their Children
  672. Regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility
  673. The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting
  674. Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children?
  675. Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity
  676. Comment on: Zoonosis: an unusual case of chronic osteomyelitis
  677. Required Treatment Expenditures for Hepatitis C Virus Infection and Advantage in the Reduction of Hepatocellular Carcinoma Incidence: Analysis of Possible Options in an Endemic Area
  678. Whole-genome resequencing of Trichophyton rubrum provides insights into population differentiation and drug resistance
  679. Anxiety and depression in adolescents with asthma and in their parents: a study in clinical practice
  680. Personalized therapies for the treatment of allergic rhinitis
  681. ADH1 promotes Candida albicans pathogenicity by stimulating oxidative phosphorylation
  682. Interplay of interferon-gamma and macrophage polarization during Talaromyces marneffei infection
  683. Re: “AA IDO1 Variant Genotype (G2431A, rs3739319) Is Associated with Severe Dengue Risk Development in a DEN-3 Brazilian Cohort” by Azevedo et al. (Viral Immunol 2019;14:296–301)
  684. Endoplasmic reticulum aminopeptidase protein 1 and Behçet’s syndrome
  685. Co-circulation of dengue, chikungunya, and Zika viruses and cross-protection
  686. Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice
  687. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism
  688. Genetic Variants (rs869109213 and rs2070744) Of the eNOS Gene and BglII in the α2 Subunit of the α2β1 Integrin Gene and Diabetic Retinopathy
  689. The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis
  690. Hodgkin lymphoma, tuberculosis and atypical radiologic image
  691. Knowledge and Practice Regarding Zika Virus Infections Among General Adults
  692. Standardization of nasal cytologic testing in the workup of allergic rhinitis
  693. A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II
  694. Anxiety and Depression in Adolescents with Severe Asthma and in Their Parents: Preliminary Results after 1 Year of Treatment
  695. Screening for Tuberculosis Among Asylum Seekers
  696. Female-to-male sexual transmssion of Zika virus infection
  697. 3 Doses versus 2 Doses Cervical Cancer Vaccination Regimen: Cost–Utility Analysis Based on Tropical Southeast Asian Country, Thailand, Situation
  698. Calcium‑sensing Receptor Polymorphisms at rs1801725 and High Circulating Calcium in Breast Cancer: Possible Molecular Explanation
  699. Congenital Zika syndrome and cerebellar cortical problem
  700. Dengue virus transmission from live donor liver graft: A comment
  701. Expected Hepatocarcinoma Cancer Rate Due to Escape Mutant among Local Population in Thailand: The Situation after the Implementation of Universal Hepatitis B Vaccination at Birth
  702. Folate intake and risk of esophageal cancer
  703. Glaucoma in Congenital Zika Syndrome
  704. Inhalation Exposure to Dioxins Air Pollutant Generated by Dead Body Incineration at Buddhist Temple: Cancer Risk Estimation
  705. Re: Impact of a Rapid Point of Care Test for Influenza on Guideline Consistent Care and Antibiotic Use
  706. Vitiligo and Hashimoto’s thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis
  707. Zika virus, blood donation and transfusion transmission risk
  708. The role of the fern test in the treatment of rhinitis
  709. Comment on: Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations
  710. Different toenail onychomycosis due to Rhodotorula mucilaginosa and Candida parapsilosis in an immunocompetent young adult
  711. Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Restless Legs Syndrome
  712. Onychomycosis with greenish-black discolorations and recurrent onycholysis caused by Candida parapsilosis
  713. Re: Prognosis of prostate cancer and prostate - specific antigen levels
  714. Diagnosis of Peroxisomal Disorders
  715. MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
  716. Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children
  717. The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy
  718. Asthma control in children and adolescents: a study in clinical practice
  719. What are the effects of rhinitis on patients with asthma?
  720. Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management
  721. MEN1-Related Hyperparathyroidism: Response to Cinacalcet and Calcium-Sensing Receptor Gene Variant Arg990Gly
  722. Parasitic Infections and Cancer: A Status Report
  723. SOCS3 ablation enhances DC-derived Th17 immune response against Candida albicans by activating IL-6/STAT3 in vitro
  724. Carpal tunnel syndrome and provocative clinical tests
  725. Genetic variations in E6, E7 and the long control region of human papillomavirus type 16 among patients with cervical lesions in Xinjiang, China
  726. Comment on the Editorial “The Plague of Plagiarism: Prevention and Cure!!!”
  727. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study
  728. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
  729. RE: Seroprevalence of Zika virus among asymptomatic pregnant mothers and their newborns in the Najran region of southwest Saudi Arabia
  730. LTP Allergy: a pragmatic and reasonable approach in clinical practice
  731. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis in Thai population
  732. Re: The Complex Interpretation and Management of Zika Virus Test Results
  733. In vitro susceptibility of dematiaceous fungi to nine antifungal agents determined by two different methods
  734. Pentraxin 3 and D‐dimer in children with asthma: A real‐world study
  735. Cladophialophora bantiana brain abscess in lung transplant recipient
  736. Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
  737. Wilms Tumor-1 (WT1) rs16754 Polymorphism
  738. Filarial tropical pulmonary eosinophilia
  739. Nasal cytology with deep learning techniques
  740. Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika and multiple arboviral immunity
  741. IL-22 Down-Regulates Cx43 Expression and Decreases Gap Junctional Intercellular Communication by Activating the JNK Pathway in Psoriasis
  742. Retracted publications in emergency medicine
  743. Direct oral anticoagulants, vitamin K antagonists, and simple single tooth extraction
  744. Infantile Acquired Vitamin B12 Deficiency
  745. HYPERTENSION, PESTICIDE EXPOSURE AND FUMIGATION WORKER
  746. Classical homeopathy for the prophylaxis of recurrent urinary tract infections
  747. Infection prevention bundle reduces surgical site infections following cranial surgery
  748. On-admission factors on attainment of therapeutic serum concentrations of magnesium sulfate in preeclampsia
  749. Vitamin D3 in children with allergic asthma in clinical practice
  750. Bet v 1 sensitization modulates allergenic molecular 1 immune response.
  751. Mal d 1 and Bet v 1 sensitization pattern in children with Pollen Food Syndrome
  752. Allergic reactions after vaccination: translating guidelines into clinical practice
  753. Visual analog scale for assessing the perception of short-acting β2-agonist use in clinical practice
  754. Serpiginoid choroiditis, tuberculosis, and sarcoidosis
  755. Whatsapp for discussing difficult cases in pathology practice
  756. Alcoholic Beverage Production in Indochina: Local Wisdom, Safety, Quality, and Legal Control
  757. Acute cholecystitis and helminthic infestation
  758. Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection presented with cardiogenic shock in a young patient
  759. Adiponectin and rheumatoid arthritis
  760. Alloimmunization in thalassemia patients
  761. Angiogenin and osteopontin and coronary collateral circulation
  762. Associations of Leptin Receptor and Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms with Polycystic Ovary Syndrome
  763. Comment on: Automation and productivity in the clinical laboratory: experience of a tertiary healthcare facility
  764. Calcium/Citrate Ratio and Risk of Kidney Stone
  765. Chagas disease, cardioembolic ischemic stroke, INR control and bleeding
  766. Chest radiographic finding: a summary on 266 Thai pulmonary melioidosis cases
  767. Clinical presentation of paragonimiasis in 73 published Thai cases: summary and comment on the change of disease pattern
  768. Coinfection between human immunodeficiency virus and tuberculosis: A consideration on ritonavir-related heme Oxygenase-1 pathway
  769. Commentary from readers: Penile fracture management
  770. Common and different lipidomes for lung cancer and tuberculosis: A comparative lipidomics analysis
  771. Concurrent dengue and tuberculosis: An estimated incidence in endemic tropical country and explanation for low observed incidence
  772. Concurrent melioidosis and tuberculosis: An expected incidence in endemic tropical country
  773. Concurrent outbreak of influenza A and dengue infection: a probability analysis for dengue and influenza A coinfection
  774. Cost-effectiveness of herpes zoster vaccination
  775. Cost-effectiveness of varicella vaccination
  776. Cost–risk analysis of available cervix cancer vaccine: Situation analysis from Thailand
  777. Cyclooxygenase-2 Gene Polymorphisms and Risk of Alzheimer's Disease: A Possible Biomoleular Explanation
  778. Dengue fever with chikungunya concurrent infection
  779. Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells
  780. Diphtheritic polyneuropathy
  781. Drug resistance pattern of Mycobacterium abscessus: Change of pattern in 20-year period after the first report of human pulmonary infection in Thailand
  782. Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs
  783. Effect of ATP-Binding cassette, Sub-Family B polymorphism on plasma nevirapine and efavirenz levels in human immunodeficiency virus with tuberculosis-infected cases: A molecular structure analysis
  784. Effect of ginseng against tuberculosis: A pathway interrelationship analysis
  785. Eosinophilic pneumonia due to the trematode parasite in the family Opisthorchiidae: species specificity and explanation by anatomical consideration
  786. Estimated prevalence of BK virus infection from screening among kidney transplant recipients: A summary from an Indochina country
  787. Expected under-recorded incidence of dengue in Thailand–Myanmar border provinces
  788. Expected advantage of urine lipoarabinomannan for tuberculosis detection in human immunodeficiency virus-endemic setting
  789. Finger and nail lesion, formaldehyde exposure, and vegetable for sale
  790. Genetic polymorphisms namely TLR2 Gene Arg753gln and Arg677trp polymorphisms and tuberculosis: Comparison on the effects of molecular weight alterations
  791. Hemoglobin A1c Level and Malnutrition/Undernutrition without Disease
  792. Incidence of pulmonary tuberculosis and particulate matter 2.5 pollutant level: The association analysis for 2019 air pollution Crisis, Bangkok Thailand
  793. Increased chances of developing cancer due to inhalation of asbestos from roof tile
  794. Influenza vaccination: Some clinical concerns for South Asian practitioner
  795. Lung hydatid cyst, an immunological process, not a pearl formation
  796. Lung sparganosis: a summary of Thai cases
  797. Microalbuminuria in dengue: Rate of occurrence and when it will be resolved?
  798. New Generation of Automated Analyzer for Pleural and Peritoneal Fluids Cytology
  799. Newly registered tuberculosis: A comparison of rate and success of management in two island districts with different in accessibility of transportation in Thailand
  800. Obstructive sleep apnea syndrome in β-thalassemia
  801. Out-of-pocket expenditure of families on the healthcare of children younger than 5 years
  802. Physician attendance during interhospital patient transfer
  803. Prevention for zika virus infection
  804. Probability of Ganciclovir Resistance in Cytomegalovirus-Infected Pediatric Kidney Transplant Recipients after Cessation of Standard Antiviral Prophylaxis: Estimated Risk on Thai cases
  805. Rabies, rabies vaccine, and renal failure: Clinical issues
  806. Ralstonia infection among hemodialysis patients: A summary
  807. Rate of children at Thailand–Myanmar border area prone to tuberculosis infection: An epidemiological prediction with referencing to bacillus Calmette–Guerin vaccination in Thailand
  808. Re: Evaluation of thyroid lesions by fine-needle aspiration cytology
  809. Re: If We Don't Ask, They Won't Tell: Screening for Urinary and Fecal Incontinence by Primary Care Providers
  810. Risk factors affecting obesity development in high school students
  811. Screening for prostate cancer starting at age 50–54 years
  812. Serosurveillance and prompt treatment of toxoplasmosis among renal recipients is needed: A path probability analysis
  813. Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes
  814. Smear-negative pulmonary tuberculosis: Relative incidence and outcome of treatment in a drug-resistant endemic setting in Indochina
  815. Sputum bacteriology of patients with acute exacerbations of bronchiectasis
  816. Star fruit-induced renal failure: Summarization of cases from Thailand
  817. Stratafix for the vaginal stump in laparoscopic hysterectomy
  818. TC2 C776G polymorphism and oral cancer
  819. Thai ethnopharmacological herbs for tuberculosis treatment: Pharmacoinformatics analysis for therapeutic property
  820. Tuberculosis screening among the patients with pulmonary silicosis
  821. Tuberculous pleural effusion: Modification of metabolome by the effect of common metabolic disease, diabetes mellitus
  822. Unsuccessful antituberculosis medication treatment: A characteristic summarization in a suburban province with dense communities of Myanmar migrant worker in Bangkok Metropolitan Region, Thailand
  823. Visit-to-visit variability in low-density lipoprotein cholesterol
  824. Zika virus during controlled ovarian hyperstimulation
  825. Change of diagnosis of tuberculosis after starting antituberculosis medication: An observation and expected rate of missed diagnosis in a Thailand–Myanmar border district
  826. Cost-effectiveness analysis of classical sputum examination versus molecular diagnosis by genexpert test for tuberculosis screening among the elderly
  827. Drug-resistant tuberculosis and cross-border patient: A retrospective analysis from a Thailand–Myanmar border area
  828. Tuberculosis case detection rate: An observation on the change in 12-year period (2005–2016)
  829. Acute abdomen as a clinical presentation of lymphoma: A case report
  830. Antibodies to dengue, Zika, Campylobacter jejuni and gangliosides in Guillain-Barre syndrome
  831. Plagiarism, Self-Plagiarism, and Text Recycling: Ethical Problem in Academic Publication
  832. Peripheral Eosinophil Counts Correlate With Nasal Eosinophil Counts in Patients With Rhinitis
  833. Parietaria Allergy: An Intriguing Challenge for the Allergist
  834. Clustering analysis in outpatients with allergic rhinitis in clinical practice
  835. Thyroid Hormone Levels in Children Receiving Antiepileptic Drugs
  836. Impaired spirometry may predict bronchial hyperresponsiveness
  837. Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery
  838. The behavior of Italian allergists in prescribing allergen immunotherapy for house dust mites allergy
  839. Chitosan whisker grafted with oligo(lactic acid) nanoparticles via a green synthesis pathway and Lidocaine encapsulation: is there any forgotten issue?
  840. Femur-sparing pattern of fetal growth after maternal Zika virus infection
  841. Homeopathy: scientific or not?
  842. Retracted or Withdrawn Publications in Plastic Surgery Journals
  843. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
  844. Mass Gatherings and Zika Virus Infection - Concerns and Facts
  845. In utero Zika virus exposure and schizophrenia
  846. Coffee waste, vector control, and dengue
  847. A combination visual analog scale as an integrated outcome for assessing the perception of allergen immunotherapy effectiveness in clinical practice
  848. The pragmatic relevance of Pru p 3 sensitization in patients with pollen allergy
  849. Genetic Polymorphism on Susceptibility to Nephrotoxic Properties of BTEXs Compounds
  850. Use of Organoids Technology on Study of Liver Malignancy
  851. Zika Virus Infection Among Pregnant Women and Their Neonates in New York City, January 2016–June 2017
  852. Eye reflux: an ocular extraesophageal manifestation of gastric reflux
  853. Electrolyte balance and voice in hemodialysis patients
  854. Hematology laboratory survey
  855. Interleukin-2-330T/G and Interleukin-10-1082A/G Genetic Polymorphisms and B-Cell Non-Hodgkin Lymphoma
  856. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
  857. Comment on: Isolated thrombocytopenia in childhood: what if it is not immune thrombocytopenia?
  858. Cerebral Infarction and Refractory Seizures in Zika Virus Infection
  859. Homeopathy: scientific or not?
  860. Late-onset congenital syphilis: is it another disease?
  861. Re: Academic integrity and plagiarism
  862. Zika virus and HIV co-infection
  863. Cortisol level and suicidal risk
  864. Immunotherapy and Asthma in Children
  865. Martin Method for Estimation of Low-Density Lipoprotein Cholesterol
  866. Apolipoprotein E polymorphism and age-related macular degeneration
  867. Is Adenoidectomy Preventable?
  868. Is there a real increased risk of stroke in patients with dengue fever?
  869. Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment
  870. The impact of Vitamin D on asthma control in clinical practice
  871. Abortion and Zika Virus Congenital Infection
  872. Comment on: Epidemiology of paediatric poisoning presenting to a children’s emergency department in Singapore over a five-year period
  873. Biomarkers of immunotherapy response in patients with allergic rhinitis
  874. The pragmatic role of nasal cytology: a point-of-care testing to implement precision medicine in clinical practice
  875. Foreign domestic workers providing long-term care for frail seniors at home
  876. Voices of HIV-infected children
  877. Correspondence
  878. Cauda equina involvement following dengue fever
  879. Electrocardiographic Finding in Zika Virus Infection
  880. Virtual Zika transmission and spread on Twitter
  881. The Human Invasive Cysticercosis by Atypical Taenia Species
  882. Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis
  883. Asthma Endotyping and Biomarkers in Childhood Asthma
  884. Early Skin Rash and Cetuximab-Based Therapy of Advanced Biliary Tract Cancer
  885. Therapeutic management of people with epilepsy in low- and middle-income countries
  886. Association of FTO rs9939609 with Obesity
  887. Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia
  888. Influenza A Infection and Stem Cell Mobilization
  889. The F1Fo-ATP Synthase β Subunit Is Required for Candida albicans Pathogenicity Due to Its Role in Carbon Flexibility
  890. Bacteriotherapy for preventing recurrent upper respiratory infections in children: a real-world experience
  891. Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilia and systemic symptoms
  892. Comment on: Haematologist-reviewed peripheral blood smear in paediatric practice
  893. Hotline for Zika virus
  894. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation
  895. Disaster Risk Reduction in Myanmar
  896. Clustering analysis in asthmatic outpatients: An experience in clinical practice
  897. Persistence of Zika Virus After Birth
  898. Responsible conduct of research
  899. Neuroimaging Findings in Normocephalic Zika Virus Infection
  900. Schistosoma Japonicum and Colon Polyps
  901. Serotonin transporter and behavioral traits
  902. The eyes as a window to improved understanding of the prenatal effects of Zika virus infection
  903. Trattamento delle riniti allergiche e vasomotorie: il ruolo del beclometasone dipropionato e dell’acido ialuronico (ad alto peso molecolare)
  904. Attempting suicide by drug overdose and its prevention
  905. Lassa fever outbreak in Africa; problem on renal failure
  906. Post retraction citations in context: a comment
  907. Clinical Profile of Ocular Cysticercosis
  908. Zika virus infection and autonomic symptoms
  909. Treatment of stress urinary incontinence with a mobile app
  910. The impact of aging on outpatients with asthma in a real-world setting
  911. Furuncular myiasis due to Cordylobia anthropophaga in a Latin American resident
  912. Methylation in the promoter regions of WT1, NKX6-1 and DBC1 genes in cervical cancer tissues of Uygur women in Xinjiang
  913. Riscos devido à exposição ocupacional aos resíduos de gases anestésicos
  914. Polimorfismo TNF-α-308 y respuesta terapéutica de espondilitis anquilosante
  915. Zika-associated Shock and Multiorgan Dysfunction: A Comment
  916. Detection of IL10-producing B cell (B10) in adenoids of atopic children with adenoidal hypertrophy
  917. Leukoagglutination, Mycoplasma pneumoniae Pneumonia, and EDTA Acid Blood
  918. Coccidioidomycosis: Imported and possible domestic cases in China: A case report and review, 1958-2017
  919. Congenital Zika syndrome in non-endemic regions
  920. Myoepithelioma of soft tissue and diagnostic pitfall in cytology
  921. Asthma symptom perception does not relate with type-2 bronchial inflammation
  922. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
  923. Cholangiocarcinoma versus small liver abscess in dual source dual-energy CT quantitative parameters
  924. Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus
  925. Re: Simplified Fournier's gangrene severe index score (SFGSI)
  926. Respiratory stress in mitochondrial electron transport chain complex mutants of Candida albicans activates Snf1 kinase response
  927. Methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy
  928. The impact of gender on asthma in the daily clinical practice
  929. Letter to ‘Knowledge and perceptions of Zika virus among reproductive-aged women after public announcement of local mosquito-borne transmission’
  930. Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity
  931. The Relevance of Nasal Cytology in the Workup of House Dust Mite-Induced Allergic Rhinitis
  932. Allergen immunotherapy and respiratory infections in children: an encouraging experience
  933. A mitochondrial proteomics view of complex I deficiency in Candida albicans
  934. Acute kidney injury due to mothball poisoning: Indian pediatric cases
  935. Acute renal failure related to cave visit: Evidence in literature and observation on the cave trapped victims in Thailand, 2018
  936. Adverse events during plateletpheresis donation
  937. Atypical zoonotic pox: Acute merging illness that can be easily forgotten
  938. Bilateral acute angle closure in a patient with dengue
  939. Bronchoscopic Characterization of Lesions and Use of Technique Accordingly During Bronchoscopy
  940. Caspase recruitment domain-containing protein 8 rs2043211 polymorphism and cardiovascular disease susceptibility
  941. Clinical investigation results of cave trapped victims in acute phase after being rescued: Data on case of 2018 cave crisis in Thailand
  942. Sonographic evaluation of abdominal organs in sickle cell disease
  943. Commentary from readers: Role of second-look transurethral resection of bladder tumors
  944. Comparison between adjuvanted and nonadjuvanted influenza vaccination among patients undergoing hemodialysis: A cost-effectiveness analysis from Thailand
  945. Congenital Toxoplasmosis, Cytomegalovirus, and Zika Virus Infections
  946. Contraception, opisthorchiasis, and cholangiocarcinoma
  947. Cost-effectiveness analysis of common tuberculosis screening laboratory tests for hemodialysis patients: An analysis from tropical endemic country, Thailand
  948. Cryptococcal antigenemia screening among human immunodeficiency virus-infected cases with tuberculosis: Chance and cost effectiveness
  949. Dengue and Japanese encephalitis E: Concurrent infection, cross reactivity, and false positivity
  950. Eye problem in Zika virus infection
  951. Fish borne acute renal failure
  952. Fosfomycin for management of persistent female lower urinary tract infection
  953. Having rs1042636C677T calcium-sensing receptor polymorphism: Increased or decreased risk for nephrolithiasis?
  954. Homosexual and Zika virus infection: Is it a new start of new problem for gay?
  955. Human babesiosis, renal failure, and dialysis: A summary and comment on forgotten disease
  956. Important Emerging and Reemerging Tropical Food-Borne Diseases
  957. Incidence of Guillain-Barré syndrome among Zika virus infected cases: a report from Thailand
  958. Interleukin-1 gene cluster polymorphisms associated with coronary slow flow phenomenon
  959. Interleukin-6 -174G/C polymorphism and end-stage renal disease: Is there any role?
  960. Intrabiliary ruptured cyst hydatid
  961. Kidney cysticercosis, cysticercosis related kidney disease and cysticercosis in patients with underlying renal problem: A Rare but important tropical renal infection
  962. Long term persistence of Zika virus after the onset of symptoms
  963. Magnitude of renal problem in fatal cases of Lassa fever: A summary on existed reports
  964. Mathematical modeling for hemoglobin change due to blood loss due to hookworm infection
  965. Medical diagnostic self-examination application: Applied medical informatics technology for supporting primary self-care
  966. Methylenetetrahydrofo late reductase C677T polymorphism and schizophrenia: Effect of molecular change
  967. Ocular manifestations of sickle cell disease
  968. Patient's bill of rights: Is it a challenge for quality health care in Saudi Arabia?
  969. Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome
  970. Protein tyrosine phosphatase, opisthorchiasis and dengue: A proteomics interrelationship
  971. Pseudomonas Aeruginosa in chronic suppurative otitis media
  972. QTc and QTcd Measurements and Their Relationships with Left Ventricular Hypertrophy in Hemodialysis Patients
  973. Quality of the ophthalmological service and satisfaction with the public healthcare system
  974. Rational use of laboratory test
  975. Renal failure in advanced cholangiocarcinoma: Magnitude
  976. Right Ventricular Outflow Tract Systolic Excursion and Fractional Shortening for the Assessment of Right Ventricular Function
  977. SLC19A1 Polymorphism and Serum Methotrexate in Patients with Acute Lymphoblastic Leukemia
  978. Targets and Receptor of Sexual Transmission of Zika Virus
  979. Thalassemia, cholangiocarcinoma, and Vitamin E deficiency: A scenario in endemic area inSoutheast Asia
  980. Tian Xian Liquid: Is it a really effective anticancer dietary supplement?
  981. Transplant recipients with cytomegalovirus and BK polyomavirus coinfection nephropathy
  982. Ultrasound and screening tool for dengue fever
  983. VSX1 and SOD1 mutation screening in patients with keratoconus
  984. Zika virus in perspective
  985. Zika Virus Infection, Pregnancy and Microcephaly
  986. Zika Virus Outbreak, assisted reproduction patients and pregnancy
  987. Zika virus infection and psychosis
  988. Zika virus infection as a trigger of atopic dermatitis
  989. Spinal intramedullary cysticercosis: A summary of three cases in Thailand
  990. Tuberculosis of patella
  991. Can a CT be Omitted in Pediatric Minor Head Trauma?: A Comment
  992. International volunteer surgical project for cleft lip/cleft palate in Laos
  993. Third cranial nerve palsy and Chikungunya virus infection
  994. Newer Vaccines against Mosquito-borne Diseases: Correspondence
  995. Sensorineural Hearing Loss and Congenital Cytomegalovirus Infection
  996. Nasal cytology: a Precision Medicine tool in clinical practice
  997. Serum magnesium level and knee osteoarthritis
  998. The impact of allergy on asthma in the clinical practice
  999. Repurposing an inhibitor of ribosomal biogenesis with broad anti-fungal activity
  1000. Concomitant testicular infection by Zika virus and Schistosoma mansoni

Showing 1,000 Stories.